Acute toxicity of conventional radiation therapy for high-risk prostate cancer in EORTC trial 22863

European Urology

Volumn 42, Issue 2, 2002, Pages 125-132

  Zurlo, A ^a   Collette, L ^a   Van Tienhoven, G ^b   Blank, L E ^b   Warde, P ^c   Dubois, J B ^d   Jeanneret, W ^e   Storme, G ^f   Bernier, J ^g   Kuten, A ^h   Pierart, M ^a   Bolla, M ⁱ  

^a EORTC DATA CENTER   (Belgium)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d CENTRE VAL D AURELLE   (France)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f Oncologisch Centrum   (Belgium)

^g OSPEDALE SAN GIOVANNI   (Switzerland)

^h RAMBAM MEDICAL CENTER   (Israel)

ⁱ Service de Cancerologie Radiotherapie   (France)

Author keywords

Conventional radiotherapy; Multiple testing; Prostate cancer; Randomised clinical trials; Toxicity

Indexed keywords

GONADORELIN AGONIST; GOSERELIN; HORMONE;

ACUTE TOXICITY; AGE; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; GASTROINTESTINAL TOXICITY; HIGH RISK PATIENT; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; RANDOMIZATION; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; TREATMENT OUTCOME; UROGENITAL TRACT INJURY; WORLD HEALTH ORGANIZATION; ADULT; CHI SQUARE DISTRIBUTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; MIDDLE AGED; NONPARAMETRIC TEST; PROSTATE TUMOR; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RISK;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; HUMAN; MALE; MIDDLE AGE; PROSTATIC NEOPLASMS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RISK; STATISTICS, NONPARAMETRIC; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME; HUMANS; MIDDLE AGED;

EID: 0036668363     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(02)00257-9     Document Type: Article

References (25)

1. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
2. Long term results of adjuvant hormonal therapy with goserelin in patients with locally advanced prostate cancer treated with radiotherapy
3. Progression in and survival of patients with locally advanced prostate cancer (T3) treated with radical prostatectomy as monotherapy
4. The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results
5. Late GI and GU complications in the treatment of prostate cancer
6. Acute toxicity in pelvic radiotherapy: A randomised trial of conformal versus conventional treatment
7. Treatment related sequelae following external beam radiation for prostate cancer: A review with an update in patients with stages T1 and T2 tumor
8. Radiotherapy of localised prostate cancer. Analysis of late treatment complications. A prospective study
9. Acute side effects and late complications after radiotherapy of localized carcinoma of the prostate
10. Treatment-related morbidity in phase III RTOG studies of extended-field irradiation for carcinoma of the prostate
11. Radiotherapy of prostate carcinoma: Results of treatment and complications
12. Acute toxicity during external beam radiotherapy for localized prostatic cancer: Comparison of different techniques
13. Low acute gastrointestinal and genitourinary toxicities in whole pelvic irradiation of prostate cancer
14. Diabetes mellitus: A predictor for late radiation morbidity
15. Quality assurance of the EORTC radiotherapy trial 22863 for prostatic cancer: The dummy run
16. Use of ranks in one-criterion variance analysis
17. Late effects after radiotherapy for prostate cancer in a randomised dose-response study: Results of a self-assessment questionnaire
18. Quality-of-life outcomes in men treated for localized prostate cancer
19. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder and sexual function: The patient's perspective
20. Natural history of prostatism: Impact of urinary symptoms on quality of life in 2115 randomly selected community men
21. Data Torturing
22. Is there more than one late radiation proctitis syndrome?
23. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: Acute toxicity and dose-volume analysis
24. Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer